Showing results (1181-1190 of 1,849) with videos related to
Sort By:
Pageof 185
Healthcare (Amsterdam, Netherlands)|July 12, 2021
Trends of hospitalizations among patients with both cancer and dementia diagnoses in New York 2007-2017Bian Liu, Katherine A Ornstein, Naomi Alpert, et al.Neurosurgery|August 1, 1990
The effect of arteriovenous malformation resection on cerebrovascular reactivity to carbon dioxideW L Young, I Prohovnik, E Ornstein, et al.Joint Commission Journal on Quality and Safety|May 25, 2004
From research to daily clinical practice: what are the challenges in "translation"?Chris Feifer, Judith Fifield, Steven Ornstein, et al.International Journal of Cancer|October 17, 2008
Annexin A2 positively contributes to the malignant phenotype and secretion of IL-6 in DU145 prostate cancer cellsJunichi Inokuchi, Navneet Narula, David S Yee, et al.Journal of Neuropsychology|March 8, 2013
Response inhibition in children with and without ADHD after traumatic brain injuryTisha J Ornstein, Jeffrey E Max, Russell Schachar, et al.ACS Medicinal Chemistry Letters|June 14, 2023
Excellence in Medicinal Chemistry: Celebrating ACS Medicinal Chemistry Division (MEDI) Awards. A Call for NominationsMaria-Jesus Blanco, Amanda Bryant-Friedrich, Gunda Georg, et al.The British Journal of Nutrition|April 2, 2008
Effect of a prebiotic mixture on intestinal comfort and general wellbeing in healthOliver Goetze, Heiko Fruehauf, Daniel Pohl, et al.Pharmacoeconomics|March 14, 2019
An Examination of Downstream Effects of Bereavement on Healthcare Utilization for Surviving Spouses in a National Sample of Older AdultsKatherine A Ornstein, Melissa M Garrido, Albert L Siu, et al.Viruses|August 28, 2021
Congenital Zika Infection and the Risk of Neurodevelopmental, Neurological, and Urinary Track Disorders in Early Childhood. A Systematic ReviewEvangelia Antoniou, Eirini Orovou, Paraskevi Eva Andronikidi, et al.Lung Cancer (Amsterdam, Netherlands)|June 16, 2009
Phase II study of the proteasome inhibitor bortezomib (PS-341, Velcade) in chemotherapy-naïve patients with advanced stage non-small cell lung cancer (NSCLC)Tianhong Li, Liawaty Ho, Bilal Piperdi, et al.Pageof 185